Structure Therapeutics announced the departure of Chief Medical Officer Mark Bach and the appointments of Blai Coll as the new CMO and Ashley Hall as Chief Development Officer, effective September 18, 2024. Dr. Bach will assist in the transition until December 31, 2024, and will receive nine months of salary and advisory fees during this period.